{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05495945",
            "orgStudyIdInfo": {
                "id": "HUM00213014"
            },
            "organization": {
                "fullName": "University of Michigan",
                "class": "OTHER"
            },
            "briefTitle": "Ultrasonic Deep Brain Stimulation During Anesthetic Sedation",
            "officialTitle": "Ultrasonic Deep Brain Stimulation During Anesthetic Sedation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "ultrasonic-deep-brain-stimulation-during-anesthetic-sedation"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-08",
            "studyFirstSubmitQcDate": "2022-08-08",
            "studyFirstPostDateStruct": {
                "date": "2022-08-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-02",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Zirui Huang",
                "investigatorTitle": "Research Assistant Professor, Anesthesiology and Research Fellow",
                "investigatorAffiliation": "University of Michigan"
            },
            "leadSponsor": {
                "name": "University of Michigan",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to see if mental functions take place during different levels of anesthesia. The researchers expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness."
        },
        "conditionsModule": {
            "conditions": [
                "Mental Function"
            ],
            "keywords": [
                "Propofol",
                "Anesthesia",
                "Ultrasound",
                "fMRI"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dorsolateral prefrontal cortex (DLPFC)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Low-intensity focused ultrasound pulsation (LIFUP)",
                        "Combination Product: Functional Magnetic Resonance Imaging (fMRI) using Propofol"
                    ]
                },
                {
                    "label": "Anterior insula cortex (AIC)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Low-intensity focused ultrasound pulsation (LIFUP)",
                        "Combination Product: Functional Magnetic Resonance Imaging (fMRI) using Propofol"
                    ]
                },
                {
                    "label": "Central thalamus (CT)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Low-intensity focused ultrasound pulsation (LIFUP)",
                        "Combination Product: Functional Magnetic Resonance Imaging (fMRI) using Propofol"
                    ]
                },
                {
                    "label": "Sham control",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Combination Product: Functional Magnetic Resonance Imaging (fMRI) using Propofol"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Low-intensity focused ultrasound pulsation (LIFUP)",
                    "description": "LIFUP will be used to stimulate specific brain regions and assess their causal involvement in the control of conscious state and contents.",
                    "armGroupLabels": [
                        "Anterior insula cortex (AIC)",
                        "Central thalamus (CT)",
                        "Dorsolateral prefrontal cortex (DLPFC)"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Functional Magnetic Resonance Imaging (fMRI) using Propofol",
                    "description": "Propofol will be administered by intravenous infusion. All anesthesia equipment, supplies, and drugs will be provided by anesthesiologists from the University of Michigan Health System. The researchers will manually control the infusion of propofol to achieve target effect-site concentrations",
                    "armGroupLabels": [
                        "Anterior insula cortex (AIC)",
                        "Central thalamus (CT)",
                        "Dorsolateral prefrontal cortex (DLPFC)",
                        "Sham control"
                    ],
                    "otherNames": [
                        "Diprivan"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Blood Oxygen Level Dependent (BOLD) response to visual stimuli",
                    "description": "Measured by fMRI",
                    "timeFrame": "Up to 90 minutes"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Perceptual criterion derived from the Signal Detection Theory (SDT)",
                    "description": "Measured by subjective reports of recognition",
                    "timeFrame": "Up to 90 minutes"
                },
                {
                    "measure": "Sensitivity derived from the Signal Detection Theory (SDT)",
                    "description": "Measured by subjective reports of recognition",
                    "timeFrame": "Up to 90 minutes"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* The participants will be right-handed adults\n* Body mass index (BMI) less than 30.\n* All subjects will be English speakers.\n\nExclusion Criteria:\n\n* Participants will be excluded if they have any medical contraindication to MRI scanning\n* Unable to undergo MRI scanning because of possible pregnancy or currently breastfeeding,\n* BMI\\>30\n* Metallic substances in the body, claustrophobia, anxiety, or cardiopulmonary disease;\n* Intracranial structural abnormality on T1-weighted MRI scans.\n* Potential subjects will be excluded if they have a history of allergy to propofol, eggs or egg products, soybean or soybean products,\n* Neurological, cardiovascular, or pulmonary illness;\n* Head injury with loss of consciousness;\n* Learning disability or other developmental disorder; sleep apnea or any severe snoring history;\n* Gastroesophageal reflux disease (GERD) or heartburn;\n* Pancreatitis or a history of pancreatitis, or sensory/motor loss sufficient to interfere with performance of the study. Participants with tattoos in the head or neck region will be excluded from study; other tattoos are subject to determination by investigators based on their assessment regarding participant safety. To eliminate aspiration risk subjects will also be excluded if they have had recent food or liquid intake (within 8 hours). Subjects will be excluded if they have a history of drug use, have a positive drug screen, are unwilling to abstain from alcohol for 24 hours prior to dosing, or have a current history of nicotine use. Women will be required to take a pregnancy test prior to participation to ensure a negative result. The pre-scan drug screen and pregnancy test will be paid for by the study.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "40 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Amy McKinney",
                    "role": "CONTACT",
                    "phone": "734-647-8129",
                    "email": "adrongo@med.umich.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Zirui Huang",
                    "affiliation": "University of Michigan",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amy McKinney",
                            "role": "CONTACT",
                            "phone": "734-647-8129",
                            "email": "adrongo@med.umich.edu"
                        },
                        {
                            "name": "Zirui Huang",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Anthony Hudetz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015742",
                    "term": "Propofol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006993",
                    "term": "Hypnotics and Sedatives"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018686",
                    "term": "Anesthetics, Intravenous"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M18307",
                    "name": "Propofol",
                    "asFound": "Inhibitor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10043",
                    "name": "Hypnotics and Sedatives",
                    "relevance": "LOW"
                },
                {
                    "id": "M20766",
                    "name": "Anesthetics, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}